相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Signaling through the Inhibitory Fc Receptor FcγRIIB Induces CD8+ T Cell Apoptosis to Limit T Cell Immunity
Anna B. Morris et al.
IMMUNITY (2020)
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
Francesca Alfei et al.
NATURE (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
Daniela S. Thommen et al.
NATURE MEDICINE (2018)
First-line treatment of metastatic melanoma: role of nivolumab
Jeremy Force et al.
IMMUNOTARGETS AND THERAPY (2017)
T cell exhaustion: from pathophysiological basics to tumor immunotherapy
Kemal Catakovic et al.
CELL COMMUNICATION AND SIGNALING (2017)
Resistance is futile: Targeting the inhibitory Fcg gamma RIIB (CD32B) to maximize immunotherapy
Ali Roghanian et al.
ONCOIMMUNOLOGY (2016)
Metastatic melanoma and immunotherapy
Benjamin Herzberg et al.
CLINICAL IMMUNOLOGY (2016)
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
Ali Roghanian et al.
CANCER CELL (2015)
Cutting Edge: Expression of Fc gamma RIIB Tempers Memory CD8 T Cell Function In Vivo
Gabriel R. Starbeck-Miller et al.
JOURNAL OF IMMUNOLOGY (2014)
CD19 and CD32b Differentially Regulate Human B Cell Responsiveness
Jodi L. Karnell et al.
JOURNAL OF IMMUNOLOGY (2014)
Tumor-Specific T Cells in Human Merkel Cell Carcinomas: A Possible Role for Tregs and T-Cell Exhaustion in Reducing T-Cell Responses
Mitra Dowlatshahi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy
Sean H. Lim et al.
BLOOD (2011)
The Inhibiting Fc Receptor for IgG, FcγRIIB, Is a Modifier of Autoimmune Susceptibility
Peter Boross et al.
JOURNAL OF IMMUNOLOGY (2011)
Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
Ann L. White et al.
JOURNAL OF IMMUNOLOGY (2011)
Ipilimumab plus Dacarbazine in Melanoma
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
Fubin Li et al.
SCIENCE (2011)
Repetitive Antigen Stimulation Induces Stepwise Transcriptome Diversification but Preserves a Core Signature of Memory CD8+ T Cell Differentiation
Thomas C. Wirth et al.
IMMUNITY (2010)
Fc gamma RIIB in autoimmunity and infection: evolutionary and therapeutic implications
Kenneth G. C. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Fc gamma RIIB in autoimmunity and infection: evolutionary and therapeutic implications (vol 10, pg 328, 2010)
Kenneth G. C. Smith et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Selective expression of inhibitory Fcγ receptor by metastatic melanoma impairs tumor susceptibility to IgG-dependent cellular response
Lvdie Cassard et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies
Seung Y. Chu et al.
MOLECULAR IMMUNOLOGY (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Tumours can act as adjuvants for humoral immunity
DM Brown et al.
IMMUNOLOGY (2001)
Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen:: A novel murine model for autoimmune glomerular basement membrane disease
A Nakamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
分享论文
